Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes

Details for Australian Patent Application No. 2009237577 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc. University of Pittsburgh - of the Commonwealth System of Higher Education

Inventors Giannoukakis, Nick; Trucco, Massimo; Brown, Larry R.

Agent Peter Maxwell & Associates

Pub. Number AU-A-2009237577

PCT Pub. Number WO2009/129544

Priority 61/048,246 28.04.08 US; 61/046,034 18.04.08 US

Filing date 20 April 2009

Wipo publication date 22 October 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

28 October 2010 PCT application entered the National Phase

  PCT publication WO2009/129544 Priority application(s): WO2009/129544

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009237578-Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring

2009237572-Exhaust apparatus, system, and method for enhanced capture and containment